DE69523605D1 - Verfahren zur herstellung vom aktieven protein dimerischen - Google Patents

Verfahren zur herstellung vom aktieven protein dimerischen

Info

Publication number
DE69523605D1
DE69523605D1 DE69523605T DE69523605T DE69523605D1 DE 69523605 D1 DE69523605 D1 DE 69523605D1 DE 69523605 T DE69523605 T DE 69523605T DE 69523605 T DE69523605 T DE 69523605T DE 69523605 D1 DE69523605 D1 DE 69523605D1
Authority
DE
Germany
Prior art keywords
production
dimeric protein
active dimeric
protein
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69523605T
Other languages
English (en)
Other versions
DE69523605T2 (de
Inventor
Nico Cerletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE69523605D1 publication Critical patent/DE69523605D1/de
Publication of DE69523605T2 publication Critical patent/DE69523605T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DE69523605T 1994-07-25 1995-07-12 Verfahren zur herstellung vom aktieven protein dimerischen Expired - Lifetime DE69523605T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810438 1994-07-25
PCT/EP1995/002718 WO1996003432A1 (en) 1994-07-25 1995-07-12 Novel process for the production of biologically active dimeric protein

Publications (2)

Publication Number Publication Date
DE69523605D1 true DE69523605D1 (de) 2001-12-06
DE69523605T2 DE69523605T2 (de) 2002-07-11

Family

ID=8218292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523605T Expired - Lifetime DE69523605T2 (de) 1994-07-25 1995-07-12 Verfahren zur herstellung vom aktieven protein dimerischen

Country Status (19)

Country Link
US (1) US6057430A (de)
EP (1) EP0775159B1 (de)
JP (2) JP3923516B2 (de)
KR (1) KR100432839B1 (de)
AT (1) ATE207933T1 (de)
AU (1) AU690311B2 (de)
CA (1) CA2194582C (de)
DE (1) DE69523605T2 (de)
DK (1) DK0775159T3 (de)
ES (1) ES2166401T3 (de)
FI (1) FI118083B (de)
HU (1) HU222830B1 (de)
IL (1) IL114701A (de)
NO (1) NO316926B1 (de)
NZ (1) NZ290373A (de)
PT (1) PT775159E (de)
TW (1) TW440566B (de)
WO (1) WO1996003432A1 (de)
ZA (1) ZA956138B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
EP0943690B1 (de) * 1995-12-21 2006-11-29 Ajinomoto Co., Inc. Verfahren zur rückfaltung von menschlichem activin a
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
US20030120042A1 (en) * 2000-03-30 2003-06-26 Takao Yamada Process for producing recombinant protein
EP1292330A1 (de) * 2000-03-31 2003-03-19 Vaccine Chip Technology APS Immunostimulierende eigenschaften eines tgf-beta-fragmentes
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
GB0514262D0 (en) * 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration
GB0604938D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0617816D0 (en) * 2006-09-11 2006-10-18 Renovo Ltd Nucleic acids and methods of protein expression
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
WO2018122794A1 (en) 2016-12-30 2018-07-05 Biogend Therapeutics Co., Ltd. Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
WO2020061067A2 (en) * 2018-09-17 2020-03-26 Board Of Regents, The University Of Texas System Texas System Compositions and methods for treating bone injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731440A (en) * 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲i▼の製造法
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors

Also Published As

Publication number Publication date
DK0775159T3 (da) 2002-02-11
NZ290373A (en) 1998-04-27
ES2166401T3 (es) 2002-04-16
DE69523605T2 (de) 2002-07-11
HUT76668A (en) 1997-10-28
EP0775159A1 (de) 1997-05-28
ATE207933T1 (de) 2001-11-15
CA2194582C (en) 2008-09-02
IL114701A0 (en) 1995-11-27
JP2007031453A (ja) 2007-02-08
IL114701A (en) 2005-11-20
HU222830B1 (hu) 2003-11-28
FI970229A0 (fi) 1997-01-20
NO970325D0 (no) 1997-01-24
WO1996003432A1 (en) 1996-02-08
JPH11505506A (ja) 1999-05-21
NO970325L (no) 1997-03-06
AU3109595A (en) 1996-02-22
CA2194582A1 (en) 1996-02-08
JP3923516B2 (ja) 2007-06-06
ZA956138B (en) 1996-03-07
TW440566B (en) 2001-06-16
FI970229A (fi) 1997-01-20
NO316926B1 (no) 2004-06-28
AU690311B2 (en) 1998-04-23
US6057430A (en) 2000-05-02
FI118083B (fi) 2007-06-29
KR100432839B1 (ko) 2004-08-30
PT775159E (pt) 2002-04-29
EP0775159B1 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
DE69523605D1 (de) Verfahren zur herstellung vom aktieven protein dimerischen
FI970258A (fi) Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi
ATE234124T1 (de) Verfahren zur herstellung von wirkstoffhaltigen knochenzementen
ATE178616T1 (de) Verfahren zur herstellung von biologisch aktivem protein (z.b. tgf)
DE69500091D1 (de) 4-Phenylamino-Pyrimidin-Derivate, Verfahren zur Herstellung und diese enthaltende Schädlingsbekämpfungsmittel für Landwirtschaft und Gartenbau
DE69525444D1 (de) Verfahren zur herstellung von biologisch aktiven siliziumverbindungen in konzentrierter form
DE69329923T2 (de) Molkenprotein und molkenproteinhydrolysate, und verfahren zur herstellung
ATE375090T1 (de) Bioaktive peptide, ihre verwendung und verfahren zu ihre herstellung
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
DE237398T1 (de) Verfahren zur herstellung biologisch aktiver polypeptide, so erhaltene polypeptide und diese enthaltende zusammensetzungen.
DE3867918D1 (de) Wachstumspromotor fuer bifidobacterium-arten, prozess zu dessen herstellung und verfahren fuer dessen anwendung.
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE60031315D1 (de) Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure
MX9700656A (es) Proceso novedoso para la produccion de proteina dimerica biologicamente activa.
MX9700657A (es) Nuevo proceso para la produccion de proteina biologicamente activa.
ATE163424T1 (de) Neue 17-(3-imino-2-alkyl-propenyl)-5beta-14beta- androstanderivate, zur behandlung von kardiovaskulären erkrankungen, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
DE60038371D1 (de) Verfahren zur herstellung von s,s-2-hydroxypropylendiamin-n,n'-di-bernsteinsäure
DE69019543D1 (de) Verfahren zur Herstellung biologisch aktiver Polysaccharid-RON-Substanz.
DE59103718D1 (de) Verfahren zur herstellung von l-lysin produzierenden mikroorganismen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

R082 Change of representative

Ref document number: 775159

Country of ref document: EP

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE